`

Drug Target Review

Book and Periodical Publishing

Specialities :
Assays
Drug targets
Omics sciences
Stem cells
Hit-to-lead

+15

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Drug Target Review

What does Drug target review do?+

Drug Target Review, published quarterly, provides a voice for the drug discovery industry, promoting the latest research and developments, funding projects, and cutting-edge technological developments. We support academia, campus companies, tech transfers, research facilities and Pharma by creating a community with the goal of educating and sharing information and news. This community of diverse individuals is able to keep up to speed with research, news and funding as it happens through print, online and workshops. SUBSCRIBE FOR FREE TODAY. http://bit.ly/2H0MBSQ

What are Drug target review's specialties? +

Assays,drug targets,omics sciences,stem cells,hit-to-lead,imaging,personalised medicine,screening,biomarkers,microbiota,microfluidics,kinases,antibodies,mass spectrometry,protein expression,enzymes,proteomics,flow cytometry,rna,and drug discovery

What is Drug target review's industry? +

Drug target review operates in the Book and periodical publishing industry.

What is Drug target review's revenue? +

Drug target review's revenue is 11m - 100m

What is Drug target review's company size? +

Drug target review has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.